2011Zhongguo Yike Daxue xuebaoRequires access

The Relationship of TOPII Expression and Neoadjuvant Chemotherapy in Breast Cancer

Feng Jin

Open publisher page 0 citations

Abstract

Objective To investigate the relationship between expression of TOPⅡ and response of neoadjuvant chemotherapy in breast cancer.Methods Core biopsy samples were obtained for assay of TOPⅡ expression before the chemotherapy and surgery.The TOPⅡ status was examined using immunohistochemistry(IHC) in 73 pairs of pre-and post-chemotherapeutic breast cancer tissues.Results TOPⅡ positive expression showed a correlation with anthracycline-based neoadjuvant chemotherapy response(P =0.005).On the other hand,the difference between pre-operative and post-operative TOPⅡ expression was statistically significant(P =0.027).The reduction of the TOPⅡ-positive cells correlated with a better pathological response to the neoadjuvant chemotherapy(P =0.017).Conclusion The results thus suggest that in breast cancer TOPⅡ may be a useful predictor of the effects of anthracycline-based neoadjuvant chemotherapy and guiding the choice of post-operative chemotherapy.

About this research paper

What this paper is about

Objective To investigate the relationship between expression of TOPⅡ and response of neoadjuvant chemotherapy in breast cancer.Methods Core biopsy samples were obtained for assay of TOPⅡ expression before the chemotherapy and surgery.The TOPⅡ status was examined using immunohistochemistry(IHC) in 73 pairs of pre-and post-chemotherapeutic breast cancer tissues.Results TOPⅡ positive expression showed a correlation with anthracycline-based neoadjuvant chemotherapy response(P =0.005).On the other hand,the difference between pre-operative and post-operative TOPⅡ expression was statistically significant(P =0.027).The reduction of the TOPⅡ-positive cells correlated with a better pathological response to the neoadjuvant chemotherapy(P =0.017).Conclusion The results thus suggest that in breast cancer TOPⅡ may be a useful predictor of the effects of anthracycline-based neoadjuvant chemotherapy and guiding the choice of post-operative chemotherapy.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the relationship between expression of TOPⅡ and response of neoadjuvant chemotherapy in breast cancer.Methods Core biopsy samples were obtained for assay of TOPⅡ expression before the chemotherapy and surgery.The TOPⅡ status was examined using immunohistochemistry(IHC) in 73 pairs of pre-and post-chemotherapeutic breast cancer tissues.Results TOPⅡ positive expression showed a correlation with anthracycline-based neoadjuvant chemotherapy response(P =0.005).On the other hand,the difference between pre-operative and post-operative TOPⅡ expression was statistically significant(P =0.027).The reduction of the TOPⅡ-positive cells correlated with a better pathological response to the neoadjuvant chemotherapy(P =0.017).Conclusion The results thus suggest that in breast cancer TOPⅡ may be a useful predictor of the effects of anthracycline-based neoadjuvant chemotherapy and guiding the choice of post-operative chemotherapy.

Key concepts: Anthracycline, Breast cancer, Chemotherapy, Immunohistochemistry, Medicine, Oncology, Pathological, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
The Relationship of TOPII Expression and Neoadjuvant Chemotherapy in Breast Cancer — Research Paper | ScholarLens